Heparin improves human osteoblast proliferation in vitro;Heparin beschleunigt die proliferation humaner osteoblasten in vitro

Orthopade

Volumn 31, Issue 6, 2002, Pages 575-581

  Matziolis, G ^a   Erli, H J ^a   Rau, H M ^a   Klever, P ^a   Bosserhoff, A K ^a   Paar, O ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Heparin; Osteoblasts; Proliferation

Indexed keywords

HEPARIN;

ARTICLE; CELL PROLIFERATION; DRUG ACTIVITY; DRUG POTENTIATION; FETAL CALF SERUM; HUMAN; HUMAN CELL; IN VITRO STUDY; LONG TERM CARE; OSTEOBLAST; OSTEOPOROSIS;

EID: 0036937659     PISSN: 00854530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00132-002-0308-y     Document Type: Article

References (33)

1. Akkas N, Yeni YN, Turan B, Delilbasi E, Gunel U (1997) Effect of medication on biomechanical properties of rabbit bones: heparin induced osteoporosis. Clin Rheumatol 16: 585-595
2. Andress DL (1995) Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells. J Biol Chem 270: 28289-28296
3. Auf'mkolk B, Hauschka PV, Schwartz ER (1985) Characterization of human bone cells in culture. Calcif Tissue Int 37: 228-235
4. Barbour LA, Kick SD, Steiner JF et al. (1994) A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 170: 862-869
5. Blanquaert F, Barritault D, Caruelle JP (1999) Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression. J Biomed Mater Res 44: 63-72
6. Chowdhury MH, Hamada C, Dempster DW (1992) Effects of heparin on osteoclast activity. J Bone Min Res 7: 771-777
7. Denk PO, Knorr M (1999) Effect of heparin on human corneal fibroblast proliferation in vitro with and without growth factor stimulation. Graefes Arch Clin Exp Ophthalmol 237: 342-347
8. Fuller K, Chambers TJ, Gallagher AC (1991) Heparin augments osteoclast resorption-stimulating activity in serum. J Cell Physiol 147: 208-214
9. Garg HG, Thompson BT, Hales CA (2000) Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 279: 779-789
10. Gennari C, Martini G, Nuti R (1998) Secondary osteoporosis. Aging (Milano) 10: 214-224
11. Gospodarowicz D, Cheng J (1986) Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128: 475-484
12. Gravlee GP (1994) Heparin-coated cardiopulmonary bypass circuits. J Cardiothorac Vasc Anesth 8: 213-222
13. Hehenberger K, Kratz G, Hansson A, Brismar K (1998) Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J Dermatol Sci 16: 144-151
14. Hurley MM, Kessler M, Gronowicz G, Raisz LG (1992) The interaction of heparin and basic fibroblast growth factor on collagen synthesis in 21-day fetal rat calvariae. Endocrinology 130: 2675-2682
15. Knudson MM, Morabito D, Paiement GD, Shackleford S (1996) Use of low molecular weight heparin in preventing thromboembolism in trauma patients. J Trauma 41: 446-459
16. Kohno M, Yokokawa K, Yasunari K, Minami M, Kano H, Mandal AK, Yoshikawa J (1998) Heparin inhibits human coronary artery smooth muscle cell migration. Metabolism 47: 1065-1069
17. Mayahara H, Ito T, Nagai H, Miyajima H, Tsukuda R, Taketomi S, Mizoguchi J, Kato K (1993) In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9: 73-80
18. Mazanec DJ, Grisanti JM (1989) Drug-induced osteoporosis. Cleve Clin J Med 56: 297-303
19. Modrowski D, Lomri A, Marie PJ (1998) Glycosaminoglycans bind granulocyte-macrophage colony-stimulating factor and modulate its mitogenic activity and signaling in human osteoblastic cells. J Cell Physiol 177: 187-195
20. Muir JM, Andrew M, Hirsh J, Weitz JI, Young E, Deschamps P, Shaughnessy SG (1996) Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood 88: 1314-1320
21. Murray WJ, Lindo VS, Kakkar VV, Melissari E (1995) Long-term administration of heparin and heparin fractions and osteoporosis in experimental animals. Blood Coagul Fibrinol 6: 113-118
22. Pillai S, Gilliam L, Conrad HE, Holleran WM (1994) Heparin and its non-anticoagulant analogues inhibit human keratinocyte growth without inducing differentiation. J Invest Dermatol 103: 647-650
23. Reilmann H, Bosch U, Barthels M (1988) Prevention of thromboembolism in surgery. Orthopaede 17: 110-117
24. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL (1991) An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 142: 257-265
25. Schmut O, Faulborn J, Trummer G (1999) Quantifying the damage to conjunctival and corneal cell cultures caused by uv light using CASY (Cell Analysis System). A method for reducing animal experiments. Ophthalmologe 96: 375-381
26. Scudiero DA, Shoemaker RH, Paull KD et al. (1988) Evaluation of a soluble tetrazolium/ formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48: 4827-4833
27. Shaughnessy SG, Hirsh J, Bhandari M, Muir JM, Young E, Weitz JI (1999) A histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in rats. Blood 93: 1231-1236
28. Shibata Y, Abiko Y, Goto K, Moriya Y, Takiguchi H (1992) Heparin stimulates the collagen synthesis in mineralized cultures of the osteoblast-like cell line, MC3T3-E1. Biochem Int 28: 335-344
29. Squires JW, Pinch LW (1979) Heparin-induced spinal fractures. JAMA 241: 2417-2418
30. Stinchfield F, Sankaran B, Samilson R (1955) The effect of anticoagulant therapy on bone repair. J Bone Joint Surg Am 28: 270-282
31. Vaananen HK (1993) Mechanism of bone turnover. Ann Med 25: 353-359
32. Walenga JM, Bick RL (1998) Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy. Med Clin North Am 82: 635-658
33. Wendel HP, Ziemer G (1999) Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 16: 342-350